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Abstract
Spinal hyperexcitability is a key event in the development of persistent pain, and arises partly fromalterations in the number and localization of
a-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)-type glutamate receptors. However, determining precisely where these
changes occur is challenging due to the requirement for multiplex labelling and nanoscale resolution. The recent development of super-
resolution light microscopy provides new tools to address these challenges. Here, we apply combined confocal/direct STochastic Optical
Reconstruction Microscopy (dSTORM) to reveal changes in calcium-permeable subunits of AMPA-type glutamate receptors (GluA1) at
identified spinal cord dorsal horn (SCDH) peptidergic axon terminals in amodel of inflammatory pain. L4/5 lumbar spinal cord was collected
from adult male C57BL/6J mice 24 hours after unilateral hind paw injection of saline or 1% carrageenan (n 5 6/group). Tissue was
immunolabelled for markers of peptidergic axon terminals (substance P; SP), presynaptic active zones (Bassoon), and GluA1. Direct
stochastic optical reconstructionmicroscopy revealeda59% increase in totalGluA1 immunolabelling in theSCDH in the carrageenangroup,
which was not detected by confocal microscopy. Cell type–specific analyses identified a 10-fold increase in GluA1 localized to SP1
structures, and identified GluA1 nanodomains that scaled with behavioural hypersensitivity, and were associated with synaptic release
sites. These findings demonstrate that dSTORM has the sensitivity and power to detect nanoscale anatomical changes in the SCDH, and
providesnewevidence for synaptic insertion ofGluA11-AMPA-Rsat spinal peptidergic nociceptive terminals in amodel of inflammatorypain.
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1. Introduction
The spinal cord dorsal horn (SCDH) is a key site in pain processing,
receiving and integrating ascending input from the peripheral
nervous system and descending modulatory input from the brain.
The mammalian SCDH circuitry is highly complex, delineated into
functionally distinct laminae,37 each incorporating numerous
diverse cell types with differing functions in somatosensation.27
Determiningpreciselywhere andhowalterations in the connectivity
and excitability of this circuitry occur is a key requirement to
elucidate the mechanisms underlying the development and
maintenance of persistent pain states, and ultimately to identify
much-needed novel analgesic strategies.
Significant recent advances have been made through the
careful anatomical characterization of spinal excitatory18 and
inhibitory6 interneurons via expression of neurochemical markers,
and the use of single-cell RNA sequencing to delineate further
subpopulations of both primary afferent fibers44 and intrinsic
SCDH neurons.21 Long-term spinal synaptic plasticity has been
demonstrated at the level of the population15 and single cell43,49
via electrophysiological recordings, and insights into the func-
tional role of some of these populations have been provided via
ablation,10 chemogenetic silencing,13 or optogenetic control.20
However, to understand how each component contributes to the
development and maintenance of spinal hypersensitivity in vivo
requires quantification of alterations in synaptic physiology in
a region- and cell type–specific manner in the intact circuitry.
Accumulation of calcium-permeable GluA1 subunits of
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid gluta-
mate receptors (AMPA-Rs) is required for calcium-dependent
synaptic plasticity in many regions of the central nervous
system.39 GluA1 is expressed on numerous cell types in rodent
spinal cord,12,35 and spinal membrane expression of GluA1, but
not GluA2, is elevated in the carrageenan model of inflammatory
pain.48 GluA1 is preferentially associated with the central
terminals of peptidergic primary afferent fibers,14,28 and func-
tional evidence suggests a switch to calcium-mediated signaling
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at these synapses in the complete Freund’s adjuvant model of
inflammation.47 However, precisely where and how GluA1
expression changes remains unknown.
To date, characterizing the underlying anatomical correlates of
plasticity has been restricted by the requirement for nanoscale
resolution, multiplex labelling, and high-throughput analysis. Super-
resolution imaging provides novel tools (reviewed in Refs. 24, 51)
capable of revealing the anatomical correlates of altered neuronal
function,32 but these are yet to be applied to spinal cord tissue or
studies of pain mechanisms. Herein, we use direct Stochastic Optical
Reconstruction Microscopy (dSTORM)38,52 to probe the spinal
correlates of persistent synaptic plasticity and the contribution of
spinalGluA1 in thecarrageenanmodel of subacute inflammatorypain.
2. Methods
2.1. Animals
Studies were in accordance with U.K. Home Office Animals
(Scientific Procedures) Act (1986) and ARRIVE guidelines.26
Twelve adult male C57BL/6J mice were used for this study
(Charles River, Margate, United Kingdom, 49-55 days at delivery).
Mice were housed in groups of 3 in individually ventilated cages in
a specific pathogen-free environment, with ad libitum access to
standard mouse chow and water.
2.2. Carrageenan model
Mice were randomly assigned to receive a unilateral intraplantar
administration of 10 mL 1% carrageenan or sterile saline (n 5 6/
group) into the right hind paw under brief isoflurane anaesthesia.
Animals were monitored for 3 hours after recovery. Pain
behaviour was assessed at baseline and 24 hours after injection
by an experimenter blinded to treatment. Fifty percent paw
withdrawal thresholds (PWTs) to von Frey filament stimulation
were determined as previously described.3 One saline-injected
animal was excluded due to a misplaced injection.
2.3. Tissue processing
Mice were transcardially perfused under terminal anaesthesia (0.2
mL Euthatal, intraperitoneally [i.p.]) with sterile saline (50 mL, 0.9%
NaCl), followed by fixation with 4% paraformaldehyde (PFA; 50mL).
The whole spinal column was removed and postfixed in 4% PFA for
48 hours. After extensivewashing in 0.1Mphosphate buffer (PB), the
lumbar enlargement of the spinal cord was dissected out of the
column, and tissue sections for combinedconfocal/STORM imaging
prepared as previously described,2 with some adaptations. Briefly,
L4/5 lumbar spinal cord was embedded in 2% agarose, marked
through the contralateral ventral graymatter with a 28G needle, and
40 mm sections cut on a Leica V1000 vibratome.
2.4. Immunohistochemistry
Sections were triple labelled through free-floating immunohisto-
chemistry for markers of peptidergic nociceptive terminals
(substance P [SP]31,34), presynaptic active zones (bassoon9,42),
and GluA11-AMPARs8,14 (see Table 1 for antibody details).
Sections were washed first in 0.1M PB, and then in 0.05M TRIS
buffered saline (TBS). Nonspecific binding was blocked and
tissue permeabilized through incubation with 1% bovine serum
albumin (Sigma, Gillingham, United Kingdom), 0.3% Triton X100
(Sigma), in TBS (1 hour, RT). Sections were then incubated first
with primary antibodies diluted in TBS (1 hour RT, 60 hours 4˚C),
followed by appropriate secondary antibodies (4 hours, dark,
Table 1) after extensive washing. Finally, sections were mounted
directly onto acetone-cleaned 183 18mm coverslips and stored
at 4˚C in the dark until imaging. Negative control sections were
incubatedwith TBS alone during primary incubations, followed by
the same combination of secondary antibodies to enable
determination of any nonspecific secondary binding.
2.5. Combined confocal/dSTORM
Immediately before imaging, sections were mounted onto
a clean glass slide using a SecureSeal imaging spacer (Grace
Labs, GBL654002, 9 mm 3 0.12 mm) containing 9 mL
abbelight smart kit (Abbelight, Paris, France). Images of the
ipsilateral dorsal horn were collected on a Zeiss Elyra PS1
combined LSM780 and super-resolution imaging platform
(Zeiss, Oberkochen, Germany) via a plan-apochromat 1003/
1.46 objective lens (Zeiss) using 30˚ immersion oil and Zen
Black imaging software.
Regions of interest (ROIs) with multiple SP1/Bassoon1 struc-
tures (presumed peptidergic nociceptive synapses) were selected
from themedial superficial SCDH,,5mm from the section surface.
Confocal z stacks (x & y: 26.57 mm, z: 3 mm, pixel size 0.104 mm)
were acquired (Supplementary Fig. 1A, available at http://links.
lww.com/PAIN/A857) and the optimal optical section selected.
Focus was maintained at this point using the automated Definite
Focus system for dSTORM imaging (Supplementary Fig. 1B,
available at http://links.lww.com/PAIN/A857). Fluorophores were
bleached through step-wise increases of 150 mW 642 nm diode
laser to 100% in TIRF-HPmodewith camera gain set to 200 (Andor
EM-CCD iXonDu 897, Belfast, Northern Ireland; pixel size 1.6mm).
2D dSTORM images were then collected for 5000 25ms cycles at
100% 642 nm power, with 2.5% 50 mW 405 nm diode laser in
transfer mode to boost photoswitching (Supplementary Fig. 1C–E,
available at http://links.lww.com/PAIN/A857). Three to four ROIs
were imaged from at least one section per animal, and 4 animals
per condition.
2.6. Image analysis
2.6.1. Confocal analysis
Single-plane, 3-channel confocal images were isolated from
3 mm z-stacks using FIJI and whole ROI mean gray intensity
determined for each channel. Area of labelling was determined
from binary images produced via Otsu auto-thresholding using
the “analyse particles” function.
2.6.2. Stochastic optical reconstruction microscopy analysis
Localisation points (LPs) from dSTORM images were produced
using the PALM module of Zeiss Zen Black with settings
determined by preliminary experiments (see Supplementary
Materials and Supplementary Fig. S2, available at http://links.
lww.com/PAIN/A857). The total number of localisations within
each field of view was then recorded and compared. For targeted
cell type–specific analysis of SP1 structures, combined confocal/
STORM analysis was performed using the in-built functions in
vividSTORM image analysis software2 (freely available from https://
sourceforge.net/projects/vividstorm/). SP1 ROIs were manually
selected from each confocal image using the free-form ROI
drawing function. Bayesian cluster analysis5 was used to identify
individual filtered GluA1 clusters within each ROI using the in-built
function within vividSTORM (see Supplementary Materials for
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details, available at http://links.lww.com/PAIN/A857). Localization
points from each cluster were then overlaid with confocal images,
and visually assessed for associationwith a synapse.Clusterswere
classified as synapse-associated if overlapping with, or directly
apposed to, confocal signal corresponding to a bassoonpunctum,
or non–synapse-associated if the closest LP was .20 nm distant
from the nearest bassoon labelling, as assessed using the ruler tool
in vividSTORM.
2.7. Statistical analyses
Data were analysed using Prism 7.0 software (GraphPad, La Jolla,
CA) using Kruskal–Wallis, Mann–Whitney U, or Wilcoxon signed
ranks tests as appropriate. Correlations were assessed using
nonparametric Spearman test. Normality of data was assessed
using D’Agostino–Pearson omnibus test, and because all data
were nonparametric, they are reported as median 6 interquartile
range (IQR). P , 0.05 was considered statistically significant.
3. Results
3.1. Carrageenan induces a sustained inflammatory pain
phenotype in mice
Intraplantar injection of saline produced no visible inflamma-
tion or change in ipsilateral PWTs at 24 hours (Figs. 1A and B).
By contrast, injection of 1% carrageenan produced significant
edema, visible within hours and still apparent after 24 hours
(Fig. 1A, right), accompanied by a pronounced reduction in
mechanically-evoked ipsilateral hind paw withdrawal thresh-
olds compared with preinjection values (Fig. 1B; median
change 255%, IQR 35%-80%, P 5 0.0156).
3.2. Confocal analyses does not detect changes in spinal
GluA1 expression after carrageenan
Regional expression patterns for immunolabelling of the neuro-
peptide SP, the presynaptic active zone scaffold protein bassoon,
and GluA11-AMPA-Rs in tissue taken from saline-treated mice
were consistent with the published literature (Fig. 2). Substance P
(SP) immunolabelling was restricted to a discrete, dense band
across laminae I-IIo of the SCDH (Fig. 2A), corresponding to the
known innervation zone of peptidergic nociceptive primary afferent
fibres. Bassoon (Fig. 2B) and GluA1 immunolabelling (Fig. 2C)
were densely accumulated in the superficial laminae, and present
throughout the dorsal horn (see Fig. 2D for composite image).
Higher magnification (1003) images reveal that SP immuno-
labelling forms a dense web of axonal labelling, with many discrete
terminal-like structures in the superficial SCDH (Fig. 2E). Punctate
bassoon (Fig. 2F) and GluA1 (Fig. 2G) immunolabelling were
frequently found in close apposition (Fig. 2H, white circles),
consistent with presynaptic and postsynaptic proteins, respec-
tively. Most SP1 structures were associated with one or more
bassoon puncta (visible aswhite regions), suggesting the presence
of multiple synaptic release sites. Although a few bassoon puncta
were associated with GluA1 puncta (white arrowheads), the
majority were not. Surprisingly, confocal microscopy did not detect
any differences in expression of any of these markers between
sections from saline- (Fig. 3A) and carrageenan-treated mice (Fig.
3B). Quantification of total SCDH GluA1 intensity (Figs. 3C–E,
5854 6 4088 vs 6904 6 6494, P 5 0.34) showed no significant
increase 24 hours after carrageenan administration. This remained
true for all markers even after restoration of confocal images
through deconvolution (Supplementary Figs. S3 and 4, available at
http://links.lww.com/PAIN/A857), suggesting that any alterations
inGluA1 expression occur at the nanoscale, below the detection of
diffraction-limited imaging techniques.
3.3. Direct stochastic optical reconstruction microscopy
imaging reveals a significant inflammation-induced increase
in spinal GluA1 labelling, particularly associated with spinal
peptidergic nociceptive terminals
To explore the potential of super-resolution imaging to detect
nanoscale alterations in protein expression, we applied dSTORM
to the same superficial SCDH field of views used for confocal
Table 1
Antibody details.
Primary antibody Supplier/Cat. no. Secondary antibody Supplier/Catalogue no.
Rat anti-substance P,31,34 1:500 BIO-RAD, Hercules, CA (8450-0505) Donkey anti-rat-AF488, 1:400 Invitrogen, Waltham, MA (A21208)
Mouse anti-bassoon,9,42 1:500 Abcam, Cambridge, United Kingdom (ab82958) Goat anti-rabbit-CF568, 1:400 Stratech (Newmarket, United Kingdom) goat anti-
rabbit IgG (111-005-003-JIR) 1 Sigma Mix-n-
Stain CF568 labelling kit (MX568S50)
Rabbit anti-GluA1,8,14 1:250 Abcam (ab31232) Donkey anti-mouse-AF647, 1:400 Invitrogen (A31571)
All antibodies have been previously validated. See Supplementary Materials (available at http://links.lww.com/PAIN/A857) for antibody specificity statement.
Figure 1. The carrageenan model of subacute inflammatory pain. (A)
Representative images of the right hind paw of adult male C57BL/6J mice
24 hours after unilateral intraplantar injection of 10 mL sterile (n 5 5) or 1%
carrageenan solution (n 5 6). One saline-treated animal was excluded due to
a misplaced injection. (B) Quantification of 50% ipsilateral PWTs at baseline
and 24 hours after injection. Data are expressed as percentage of the
contralateral PWT at each time point. Lines 5 median, error bars 5 IQR.
Within-group changes in PWT over time were assessed using one-tailed
Wilcoxon matched-pairs signed rank tests, *P 5 0.0156. IQR, interquartile
range; PWT, paw withdrawal threshold.
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analyses. Unlike confocal imaging, dSTORM identified a sub-
stantially larger number of individual GluA1 localizations in
carrageenan-treated mice (Fig. 3F–H; 59% increase, carra-
geenan 5 134,731 6 28,566, saline 5 84,926 6 50,411, P 5
0.0143). This direct comparison between dSTORM and confocal
reveals the importance of analysing anatomical correlates of
synaptic physiology with nanoscale resolution.
The central terminals of SP-expressing peptidergic nociceptive
primary afferent fibres have been identified as the preferential site
for functional GluA1-AMPA-R expression in the rodent superficial
SCDH.14,28 We therefore set out to determine how GluA1
expression associated with spinal SP1 structures is altered in the
presence of subacute inflammatory pain. Individual SP1 structures
containing at least one bassoon punctum (indicative of the
presence of a synapse) were selected as ROIs in confocal images
using vividSTORM (Fig. 4; saline: 191 SP1/bassoon1 ROIs;
carrageenan: 231 ROIs). To determine the impact of the
inflammatory pain model on the properties of these terminals, the
number, size, and labelling intensity of each ROI were quantified.
There was a trend towards increased number (Fig. 5A carra-
geenan5 116 5, saline5 86 2, P5 0.0571) and area (Fig. 5B;
carrageenan5 2.36 0.7, saline5 1.86 0.5 mm2, P5 0.0571) of
SP1/bassoon1 structures in the SCDH of carrageenan-injected
mice, suggesting a possible increase in the size and density of
peptidergic nociceptive primary afferent terminals induced by the
inflammatory pain state. Thus, all subsequent data were normal-
ised to ROI area. There were no significant differences in the
average number of bassoon puncta associated within each SP1
ROI (Fig. 5C; carrageenan 5 1.3 6 0.5, saline5 1.5 6 0.3/mm2,
P 5 0.49), suggesting no change in the number of synapses
formed by each terminal. However, the total number of GluA1
dSTORM localisations associated with SP1 ROIs was almost 10-
fold higher in the carrageenan-injected group (Fig. 5D;
carrageenan 5 2560 6 2004, saline 5 272 6 105, P 5 0.0143).
Correlation analysis revealed that the number of SP-associated
GluA1 localisation points varied inversely with the change in
ipsilateral PWTs in the carrageenan-treated group, although this
did not reach significance (Fig. 5E; r 5 20.8, P 5 0.1667).
3.4. Targeted analysis of SP1 terminals reveal increased
number, but not size, of GluA11 nanodomains and an
increase in the synapse-associated population
GluA2-containing AMPA-Rs at excitatory synapses in hippocam-
pus are arranged in 70 to 80 mm nanodomains.30,33 To determine
whether GluA11-AMPA-Rs in peptidergic nociceptive primary
afferent terminals are similarly organised, Bayesian cluster analysis
was performed on GluA1 LPs associated with SP1/bassoon1
ROIs. This analysis identified numerous;130 nm clusters of GluA1
localisation points, with a significantly larger number of these GluA1
nanodomains associated with SP1 structures in carrageenan-
injectedmice (Fig. 5F; carrageenan5 2.860.7 saline5 1.860.7,
P 5 0.0143). Interestingly, neither the median number of LPs per
cluster (Fig. 6A; carrageenan 5 98 6 10, saline 5 91 6 16, P 5
0.1714) nor the diameter of individual GluA1 dSTORMclusters (Fig.
6B; carrageenan 5 140 6 11 nm, saline 5 127 6 27 nm, P 5
0.1714) was altered in the model of inflammatory pain. Plotting the
cumulative frequency analysis of these data confirmed virtually
identical size distributions (Figs. 6C and D).
To ascertain the potential functional significance of our data, we
then asked whether the increase in GluA1 clusters was biased
towards association with bassoon immunolabelling, and therefore
synaptic release sites. This analysis demonstrated a small 14%
increase in non–bassoon-associated extrasynaptic GluA1 clusters
in carrageenan-treated mice (Fig. 6E, P5 0.1714), but a far larger
34% increase in the number of GluA1 clusters overlapping with, or
Figure 2. Triple immunolabelling of Substance P (SP), Bassoon, and GluA1 in the spinal cord dorsal horn (SCDH). Representative 203 confocal images of (A) SP,
(B) bassoon, and (C) GluA11-AMPA-R immunolabelling in the SCDH of a saline-treated mouse. Amerged image of all 3 channels can be seen in (D). Scale bars5
50mm. High-magnification (1003) single-channel images showing immunolabelling for (E) SP, (F) bassoon, and (G) GluA11-AMPA-R taken from the boxed region
in (D). (H) Merged image showing an overlay of all 3 channels. White circles highlight close appositions of bassoon and GluA1, and white arrowheads indicate SP1
structures containing bassoon–GluA1 appositions. Scale bars 5 5 mm.
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directly apposed to, bassoon (Fig. 6F; carrageenan5 1.26 0.4 vs
saline 5 0.9 6 0.4, P 5 0.0286). Comparison of the frequency
distributions reveals little change in non–synapse-associated
GluA1 (Fig. 6G) but that the number of bassoon puncta without
detectableGluA1was almost halved 24hours after induction of the
carrageenan model (Fig. 6H; carrageenan 5 15.85%, saline 5
31.25%). This analysis also identified a small population of ROIs
with a very high number of bassoon-associated GluA1 clusters
(.6) in the sections from the carrageenan model.
4. Discussion
To the best of our knowledge, this is the first study to apply
STORM super-resolution imaging to probe the anatomical
correlates of pain. Super-resolution microscopy can precisely
determine the nanoscale distributions of target molecules1,11,46
and reveal previously inaccessible subdiffraction limit structural
motifs.16,40,50 Herein, the exquisite sensitivity of dSTORM
revealed that behavioral hypersensitivity in the mouse carra-
geenan model of subacute inflammatory pain is accompanied by
increased expression of calcium-permeable GluA11-AMPA-Rs
in the SCDH. Cell type–specific analyses identified a substantial
contribution of GluA1 associated with SP1 structures, the
majority of which are central terminals of peptidergic nociceptive
primary afferent fibers.25,41 As the number of individual GluA1
nanodomains scaled with the extent of hypersensitivity, we
suggest increased unitary addition of GluA1 nanodomains as
a potential anatomical correlate of inflammatory pain.
4.1. Increased spinal GluA1 expression at spinal peptidergic
nociceptive terminals
Peripheral injection of carrageenan produces biphasic inflamma-
tion, with a rapidly developing initial component resolving within 6
Figure 3.Direct stochastic optical reconstruction microscopy (dSTORM) imaging reveals a significant inflammation-induced increase in spinal GluA1 labelling not
detected by confocal microscopy. Representative 1003 images of Substance P, bassoon, and GluA1 immunolabelling in the medial superficial spinal cord dorsal
horn 24 hours after saline (A) or 1% carrageenan treatment (B). Single-channel confocal (C and D) and unfiltered dSTORM (F and G) images of GluA1
immunolabelling in the same fields of view shown in (A andB). STORM images include all localisations detected from5000 imaging cycles (seeMethods for details).
Scale bars 5 5 mm. Quantification of confocal mean gray intensity values (E) or total number of STORM localisation points (H) for whole FOV 1003 GluA1
immunolabelling. Data are mean values from 3 to 5 field of view per animal, 4 animals per group. Line 5 median, error bars 5 IQR. *P 5 0.0143, one-tailed
Mann–Whitney U test.
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hours, and a more pronounced late phase peaking at 24 to 48
hours and persisting for up to 4 days.22,36 The latter subacute
phase was studied here because it is associated with plasticity in
spinal nociceptive circuitry, and altered ion channel expression in
primary afferent fibres.29
Substantial upregulation of GluA1, but not GluA2, has been
previously been demonstrated in isolated lumbar spinal cord
membrane fractions in the carrageenan model through Western
blotting.48 However, subsequent immunohistochemical analyses
detected no change in total GluA1 in the superficial SCDH.
Similarly, we report that confocal microscopy was unable to detect
an alteration in total GluA1 immunolabelling in the superficial SCDH
24 hours after carrageenan, even after image restoration through
deconvolution. By contrast, dSTORM analyses of the same
immunolabelling identified a 59% increase inGluA1, demonstrating
the enhanced sensitivity of STORM compared with diffraction-
limited imaging techniques. Virtually, all AMPA-Rs in the superficial
laminae of the rodent spinal cord, including all GluA11 receptors,
contain GluA235; therefore, increased GluA1 expression either
represents replacement of GluA1-negative AMPA-Rs with hetero-
mers containing both GluA1 and GluA2, or insertion of additional
GluA11 receptors. This increase in GluA1 immunolabelling was
significant despite variability in expression levels between animals,
and relatively small group sizes, and therefore dSTORM imaging
also has the potential to reduce the numbers of animals required in
future anatomical studies.
Alongside increased resolution, another major advantage of
STORM is its compatibility with multiplex fluorescent immuno-
labelling. This enables large-scale quantitative cell type–specific
analyses that are extremely laborious and expensive to perform
through electron microscopy. We took advantage of this to focus
our investigations on SP1 structures containing at least one
synapse, the majority of which are the central terminals of
peptidergic nociceptive primary afferents,25,41 where GluA1
subunits are preferentially expressed.14,28 It is important to note,
however, that a population of intrinsic spinal neurons also express
SP17 and have some axons projecting to lamina I,19 and are
involved in nociceptive signalling. It is possible that some
terminals arising from these cells form a portion of the structures
analysed here. For clarity, we have therefore used the terminology
of spinal peptidergic nociceptive terminals throughout. In
structures immunoreactive for the neuropeptide SP and the
presynaptic active zone marker bassoon (and thus the presumed
presence of a nociceptive peptidergic synapse), we report 10-
fold higher levels of GluA1 in carrageenan-treated mice com-
pared with saline-treated controls. The higher levels of GluA1
expression in SP1 structures were associated with lower
mechanical pain thresholds in carrageenan-treated mice, but
not in saline-treated mice, although this association did not reach
statistical significance. These data suggest that GluA1 expression
at spinal peptidergic nociceptive terminals is unrelated to basal
mechanical pain sensitivity, but scales with behavioural hyper-
sensitivity after an inflammatory insult, further supporting a func-
tional link between calcium-permeable AMPA-R expression,
synaptic plasticity, and pain behavior in this model of inflamma-
tory pain.
4.2. Increased numbers of individual GluA11-AMPA-R
nanodomains at spinal peptidergic nociceptive terminals
Recent work identified the role of transsynaptically aligned
nanodomains in the regulation of neurotransmission,4 and
super-resolution imaging has been used to demonstrate nano-
scale clustering of glutamate receptors in 70 to 80 nm domains at
hippocampal excitatory synapses.30,33 Here, we used Bayesian
cluster analysis to identify individual GluA1 nanodomains
associated with spinal peptidergic nociceptive terminals. We
report the presence of numerous discrete ;130 nm GluA1
nanodomains, and demonstrate a 54% increase in their number
in carrageenan- vs saline-treatedmice, with no significant change
in their size or density. These nanodomains are larger than those
previously described for GluA2,30,33 which may be accounted for
by the larger size of central primary afferent fiber terminals
compared with hippocampal synapses. The presence of a small
population of terminals with a very high number of GluA1 clusters
raises the intriguing possibility that synaptic plasticity in just a few
individual terminals could have a significant contribution to altered
nociceptive signaling in inflammatory pain states. Importantly, the
increase in average number, but not size, of GluA1 nanodomains
is concordant with reports in hippocampal spines,23 where
synaptic strength scales with synapse size through coordinated
addition of unitary synaptic modules, rather than increase in
individual unit size. Our data indicate that similar principles may
govern the organization of spinal GluA1, and point to a functional
alteration in glutamate sensitivity at spinal peptidergic nociceptive
terminals as an anatomical correlate of subacute inflammatory
pain.
4.3. Increased GluA1 clusters at synaptic release sites of
spinal peptidergic nociceptive terminals
Previous investigations in inflammatory pain models failed to
show a change in total spinal GluA1 expression through
Figure 4. Targeted cell type–specific analyses of SP1 structures. (A) Overlay of
3-channel confocal image and GluA1 STORM localisation points (dark blue)
taken from a representative section in a saline-treated mouse. (B–D) An
enlargement of the boxed region in (A), showing a SP1 structure with 2
associated bassoon puncta (magenta/white) and all GluA1 STORM local-
isation points (B), and the same structure after density and photon filtering of
STORM localisations (C), and after manual selection of the ROI and Bayesian
cluster analysis to isolate individual GluA1 clusters (D). Each cluster was
designated as synapse-associated (S) or non–synapse-associated (NS) based
on visual analyses of overlap with or proximity to bassoon labelling.
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diffraction-limited light microscopy, but indicated a shift in the
proportion of GluA1 immunolabelling associated with the
synaptic marker synaptophysin.48 Physiological data from the
complete Freund’s adjuvant model has also identified a switch to
calcium-mediated signalling at synapses expressing the receptor
for SP, NK1-R.47 Taken together, these observations suggest
that specific synaptic insertion of GluA1 may be a key feature of
synaptic plasticity in subacute inflammatory pain.
To interrogate synapse-specific changes in our data set, we
determined whether GluA1 clusters in SP1 structures were
preferentially associated with the presynaptic active zone marker
bassoon, and thus the presumed position of a synapse. A slight
increase in extrasynaptic (non–bassoon-associated) GluA1
clusters was observed, which may contribute to altered synaptic
physiology through detection of volume transmission or synaptic
overflow of glutamate. However, the largest difference was in
synapse-associated GluA1. The average number of GluA1
clusters associated with each SP1 synapse was significantly
higher in carrageenan-treated mice when compared with saline-
treated controls, and the population of SP1 synapses without
detectable GluA1 immunoreactivity was halved. These data
further support the specific synaptic insertion of calcium-
permeable AMPA-R subunits at spinal peptidergic nociceptive
terminals in the model of inflammatory hyperalgesia.
4.4. Study limitations
We note several caveats relating to the study design and some
inherent technical limitations of the approach. As with all
immunohistochemical approaches, dSTORM is reliant on the
affinity and specificity of the antibodies (see Supplementary
Materials, available at http://links.lww.com/PAIN/A857). It should
Figure 5. Targeted dSTORM analyses reveal increased GluA1 at spinal SP1 nociceptive terminals. Quantification of SP1Bassoon1 ROIs reveals a trend towards
increased average number per FOV (A), and individual ROI area (B), but no change in the number of bassoon puncta associated with each ROI (C) in carrageenan-
treated mice (median 6 interquartile range). Quantification of carrageenan-induced changes in GluA1 clusters associated with SP1Bassoon1 ROIs (all data
normalised to ROI area in mm2, line 5 median, error bars 5 interquartile range) demonstrates a significant increase in the average total number of GluA1 LPs
associated with individual SP1 ROIs in carrageenan-treated mice (D). The average number of GluA1 localisations correlates with pain behaviour in individual
carrageenan-treated, but not saline-treated, mice (E). Pain behaviour is expressed as % change in normalised ipsilateral PWTs, and correlations assessed using
Spearman’s r. The average number of GluA1 clusters associated with SP1 ROIs is also increased in carrageenan- vs saline-treated mice, normalised to ROI area
(F). Individual clusters were identified through Bayesian cluster analysis for each SP1Bassoon1ROI. *P, 0.05, Mann–WhitneyU test. dSTORM, direct stochastic
optical reconstruction microscopy; FOV, field of view; LP, localisation point; PWT, paw withdrawal threshold; ROI, region of interest.
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Figure 6. Increased number, but not size or density, of GluA11 nanodomains associated with spinal SP1 nociceptive terminals as an anatomical correlate of
inflammatory pain. Quantification of the average number of GluA1 dSTORM localisationswithin each individual nanodomain (A), and the average diameter of GluA1
nanodomains (B) show no significant changes 24 hours after carrageenan. The corresponding cumulative frequency distributions (C and D) reveal largely
overlapping populations, except for the presence of a small number of very large nanodomains (diameter.0.5 mm) in the carrageenan-treated group. Individual
analyses of identified GluA1 nanodomains revealed a small, nonsignificant increase in the non–bassoon-associated population (E) but a larger increase in GluA1
associatedwith bassoon puncta (F). Cumulative frequency analyses reveal largely overlapping distributions of non–bassoon-associatedGluA1 (G), but a rightward
shift in the number of GluA1 nanodomains associated with bassoon puncta (H). Individual data points represent mean values for individual animals, lines5 group
median values, error bars 5 interquartile range. *P , 0.05, one-tailed Mann–Whitney U tests. LP, localisation point; dSTORM, direct stochastic optical
reconstruction microscopy.
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be noted that localisation precision is limited by the size of the
antibody complex (;7-8nm per IgG45), and the pixel size of the
detectors, rather than the theoretical limit of the size of
fluorophore (;1 nm). Despite the increased sensitivity of STORM
compared with diffraction-limited imaging approaches, there is
still a limit of detection, and a lack of labelling should not be
interpreted as total absence of protein; thus, our numerical
findings are not absolute, eg, the proportion of structures
containing GluA1. The synaptic markers in this study were
imaged through less sensitive confocal microscopy, and some
weakly immunoreactive structures may therefore have been
missed, leading to some synaptic GluA1 clusters being in-
correctly attributed. However, we note that the proportion of
synapses lacking GluA1 in saline-treated animals detected herein
(31.25%) closely approximates that reported for the whole
superficial dorsal horn (;35%).35 Future studies using multichan-
nel dSTORM will enable more precise determination of the
relationship between key synaptic components, and how this
nanoscale organization contributes to plasticity.
Direct stochastic optical reconstruction microscopy cannot be
considered truly quantitative due to the nonlinear relationship
between antigen, primary antibody, secondary antibody, and
fluorophore, and the probability of individual fluorophores un-
dergoing multiple photoswitching cycles. Thus, whether LPs in
close proximity indicate the presence of multiple GluA11-AMPA-
Rs, a single AMPA-R multiply labelled with primary and/or
secondary antibodies, or a single receptor-antibody complex in
which the fluorophore underwent multiple photoswitching cycles
cannot be distinguished. However, these considerations are
applicable across all experimental conditions, and therefore the
ratiometric comparisons used here are robust and are unlikely to
impact on effect size.
A final consideration is that pools of AMPA-Rs are not static,
but highly dynamic,7 with changes in their mobility underpinning
aspects of synaptic plasticity. Our use of fixed tissue in this study
provides only a single snapshot of GluA1 localisation, and thus
future studies using single-molecule tracking super-resolution
imaging techniques such as uPAINT or sptPALM will be required
to determine the time course and dynamics of inflammation-
induced alterations in spinal GluA1 expression.
5. Conclusion
In the carrageenan model, inflammatory pain was accompanied
by increased expression of calcium-permeable GluA11-AMPA-
Rs in the SCDH. A substantial proportion of GluA11-AMPA-Rs
were associated with spinal peptidergic nociceptive terminals
and the number of individual GluA11 nanodomains at these
terminals scaled with behavioral hypersensitivity. Many more
GluA1 nanodomains were associated with the presynaptic active
zone marker bassoon, supporting synaptic insertion of calcium-
permeable AMPA-R subunits at spinal peptidergic nociceptive
terminals as a functional marker in this model of inflammatory
hyperalgesia.
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